Knopp Biosciences was featured as both the cover story, detailing the company’s recent hypereosinophilic syndrome (HES) trial, as well as in a key editorial entitled “Dexpramipexole: a new antieosinophil drug?” in the August 2, 2018 edition of Blood. The editorial, … Continued
Milford, CT, May 22, 2018 –(PR.com)– Penna, the U.K.’s foremost talent management company, now part of the Adecco group, have entered into a new service agreement with Express KCS, focused on providing expanded services into digital ad operations and campaign … Continued
Knopp Biosciences LLC today announced the publication of a report in the journal Bloodthat a Phase 2 study of dexpramipexole in hypereosinophilic syndromes (HES) met its co-primary endpoints. A team of investigators led by Dr. Amy Klion at the National Institute … Continued
“For individual investors, getting in on asset classes like commercial real estate or litigation finance has been difficult due to barriers like lack of capital. Now the technology platform and lender YieldStreet is helping accredited investors get in on asset-based … Continued
NEW YORK–(BUSINESS WIRE)–YieldStreet, the alternative investment platform striving to change the way wealth is created, today announced strong company growth to close out Q1 2018, including: Over $317M invested by retail investors since inception in 2015. This represents a year … Continued
Trunomi, a Bermuda and London, UK-based provider of customer consent and data rights and privacy software solutions, received a $3.5m round of financing. CloudScale Capital Partners participated in the funding. The company intends to use the funds to manage the … Continued
Have you ever thought that there had to be a better way of doing something? You look at a situation and just know deep down that things need to change. For Milind Mehere, that moment came when he was, in his … Continued
With the stock market soaring to new highs, you may be thinking about diversifying your portfolio. However, there are not that many options that are uncorrelated to the stock market that are readily available and easy to access. Introducing YieldStreet, the … Continued
What does your company do? What unique problem does it solve? Stuart Lacey, CEO: Trunomi unlocks the power of customer data using consent and data rights. Trunomi provides customer consent and data rights management technology which enables businesses to request, … Continued
YieldStreet Inc., a New York-based startup that packages and sells business loans to investors, said it raised $113 million in debt and equity to expand its offerings. The three-year-old company specializes in loans to real-estate projects, small businesses and law … Continued
